Zoya completed her Ph.D. and postdoctoral research at the University of Chicago, where she co-invented Sensona’s nanoparticles synthesis and the PURE-PCR technology. She has 17+ years of experience in DNA nanotechnology, focusing on developing biosensors and optical imaging of cancer for clinical applications. Expert in nucleic acid amplification methods, including ultra-sensitive DNA nanomachines for diagnostics of infectious diseases. Author of 17 scientific papers, coordinator of international grants, and co-inventor of 10 patents.
B.S., M.S. The Hebrew University of Jerusalem (Chemistry), Ph.D. The University of Chicago (Chemistry)
Yossi Weizmann's, Professor of Chemistry expertise sits at the cutting edge of the chemistry, biology, and materials science fields with various interdisciplinary approaches, including bioelectronics, DNA nanotechnology, surface chemistry, and novel nanomaterials. He has 20+ years' extensive background in nucleic acid amplification methods and designing bioelectronic sensors, with profound experience in developing ultrasensitive bio-electronic and optical detection schemes for nucleic acids and proteins. Professor Weizmann has 70+ peer-reviewed publications and 15 patents
Ph.D. The Hebrew University of Jerusalem (Chemistry), Post-doctorate MIT
Mike Buhle joined Sensona’s Advisory Board in 2019, bringing more than 25 years of commercial leadership experience across the clinical and life sciences sectors. He has led business development, marketing, operations, and strategic partnerships, with particular expertise in molecular biology, oncology, precision medicine, and innovative diagnostic and laboratory technologies.
Mike currently serves as CEO of Aspira Women’s Health and has previously held executive roles at Biovision Diagnostics, Congenica, and Danaher Corporation, where he drove market-share growth, launched cutting-edge platforms, and built high-performing commercial and operational teams.
He holds a Bachelor’s degree in Business Management from Clarke University and is passionate about advancing technologies and clinical solutions that improve patient outcomes
Amir Lichtenstein (Ph.D.) brings to Sensona decades of productive and successful work turning innovative ideas into products. He was RAM GROUP Global's PD, the GreinDX AS CTO, Traceense LTD, Physical Logic AG, and Sienna Cancer Diagnostics (Sensogene). Amir has 30+ years of experience in Microbiology, focusing on developing DNA-based biosensors and early cancer diagnostics for point-of-care applications. He authored 29 patents and peer-reviewed articles, among them Nature Biotechnology and Nature Communications
Nimrod Weizmann, MD, is an expert in OB/GYN, Infertility, and STDs with extensive experience in the diagnosis and treatment of sexually transmitted diseases. Nimrod is the head of the Emergency Obstetrics and Gynecology Department and ER. He is a primary care doctor, and an attending physician Ob/GYN at Laniado Hospital, Netanya. Dr. Weizmann’s outstanding skills, problem-solving ability, and network of professional contacts in the medical and gynecologic fields help Sensona to identify areas for further development and to complete its goals with maximum productivity
Michael has over 40 years of experience in financing, negotiating, and marketing management. His knowledge and skills to work with providers and to manage the sales force play a crucial role in Sensona's projects. Michael primary focus in Sensona is on forecasting business opportunities, hiring, and training personnel
M.A. Loyola University, OPM Harvard Business School
Revolutionizing rapid diagnostics through innovative nanotechnology.
Delivering 90-second PCR-based testing for infectious diseases at the point of care.
Get the latest news and updates from SENSONA